AI Insight
Researchers have developed a method to enhance natural killer cells, a type of immune cell, enabling them to infiltrate solid tumors and maintain their cancer-fighting activity within the tumor environment. These engineered tissue-resident natural killer cells demonstrated the ability to slow tumor growth in mouse models of melanoma and head and neck cancers. The therapeutic effect was further amplified when combined with cetuximab, an existing antibody-based cancer drug.
Why it matters
This approach could offer a new immunotherapy strategy for treating solid tumors, which have historically been difficult targets for immune-based treatments. The synergy with existing antibody drugs suggests potential for combination therapies that could improve outcomes for cancer patients.
Understand the Science
Researchers have found a way to supercharge natural killer cells, powerful immune cells that can attack cancer, so they can penetrate solid tumors and keep fighting once inside. In mice, these specially prepared tissue-resident cells slowed the growth of several tumors, including melanoma and head and neck cancers, and worked even better when paired with the antibody drug cetuximab.
Source: Supercharged “natural killer” cells could be a powerful new cancer weapon